Meanwhile, other molecular biomarkers indicating worse outcome in IDH‐mutant astrocytoma, including NOTCH1 mutations and incomplete resections in oligocytoma and PIK3R1 mutations, RB1 mutations and CDK4 mutations and amplifications in astrocytoma.26, 27. This evidence concerns the gene PIK3R1 and astrocytoma (excluding glioblastoma).